Skip to content

Clinical trials

Phase 4 Obesity trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 4 Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20112
20122
20172
20181
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
InQpharm Group3
ClinTrio Ltd.1
Heilpflanzenwohl AG1
Novartis Pharmaceuticals1
Novo Nordisk A/S1
Takeda1
Technical University of Munich1
University of Bonn1
University of Ulm1
Universitätsklinikum Hamburg-Eppendorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity12
Overweight5
Weight Loss3
Body Weight1
Diabetes Mellitus1
Hypertension1
Insulin Resistance1
Metabolic Syndrome1
Plaque, Amyloid1
Polycystic Ovary Syndrome1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.